{"meshTagsMajor":["Genes, ras","Molecular Targeted Therapy"],"meshTags":["Adenocarcinoma","Adenoma","Animals","Antineoplastic Agents","Cell Aging","Cyclin-Dependent Kinase 4","Drug Screening Assays, Antitumor","Gene Expression Regulation, Neoplastic","Genes, ras","Humans","Lung Neoplasms","Mice","Molecular Targeted Therapy","Mutation","Piperazines","Protein Kinase Inhibitors","Proto-Oncogene Proteins","Proto-Oncogene Proteins p21(ras)","Pyridines","RNA Interference","RNA, Small Interfering","ras Proteins"],"meshMinor":["Adenocarcinoma","Adenoma","Animals","Antineoplastic Agents","Cell Aging","Cyclin-Dependent Kinase 4","Drug Screening Assays, Antitumor","Gene Expression Regulation, Neoplastic","Humans","Lung Neoplasms","Mice","Mutation","Piperazines","Protein Kinase Inhibitors","Proto-Oncogene Proteins","Proto-Oncogene Proteins p21(ras)","Pyridines","RNA Interference","RNA, Small Interfering","ras Proteins"],"genes":["CDK4","KRAS"],"publicationTypes":["News"],"title":"[CDK4, a specific target in the treatment of lung adenocarcinomas mutated for KRAS].","pubmedId":"21187034"}